Loading...
Frontline Treatment of Localized Osteosarcoma Without Methotrexate: Results of the St. Jude Children's Research Hospital OS99 Trial
BACKGROUND: Standard treatment of osteosarcoma includes cisplatin and high-dose methotrexate (HDMTX); both agents exert significant toxicity, and HDMTX requires complex pharmacokinetic monitoring and leucovorin rescue. In our previous OS91 trial, treatment of localized disease with carboplatin, ifos...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3535449/ https://ncbi.nlm.nih.gov/pubmed/21656756 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25715 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|